Literature DB >> 16719987

Compartmentalization of the inflammatory response in sepsis and SIRS.

Jean-Marc Cavaillon1, Djillali Annane.   

Abstract

Sepsis and systemic inflammatory response syndrome (SIRS) are associated with an exacerbated production of both pro- and anti-inflammatory mediators that are mainly produced within tissues. Although a systemic process, the pathophysiological events differ from organ to organ, and from organ to peripheral blood, leading to the concept of compartmentalization. The nature of the insult (e.g. burn, hemorrhage, trauma, peritonitis), the cellular composition of each compartment (e.g. nature of phagocytes, nature of endothelial cells), and its micro-environment (e.g. local presence of granulocyte-macrophage colony stimulating factor [GM-CSF] in the lungs, low levels of arginine in the liver, release of endotoxin from the gut), and leukocyte recruitment, have a great influence on local inflammation and on tissue injury. High levels of pro-inflammatory mediators (e.g. interleukin-1 [IL-1], tumor necrosis factor [TNF], gamma interferon [IFN-gamma], high mobility group protein-1 [HMGB1], macrophage migration inhibitory factor [MIF]) produced locally and released into the blood stream initiate remote organ injury as a consequence of an organ cross-talk. The inflammatory response within the tissues is greatly influenced by the local delivery of neuromediators by the cholinergic and sympathetic neurons. Acetylcholine and epinephrine contribute with IL-10 and other mediators to the anti-inflammatory compensatory response initiated to dampen the inflammatory process. Unfortunately, this regulatory response leads to an altered immune status of leukocytes that can increase the susceptibility to further infection. Again, the nature of the insult, the nature of the leukocytes, the presence of circulating microbial components, and the nature of the triggering agent employed to trigger cells, greatly influence the immune status of the leukocytes that may differ from one compartment to another. While anti-inflammatory mediators predominate within the blood stream to avoid igniting new inflammatory foci, their presence within tissues may not always be sufficient to prevent the initiation of a deleterious inflammatory response in the different compartments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16719987     DOI: 10.1179/096805106X102246

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  85 in total

1.  Cell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages.

Authors:  Andrew Baird; Raul Coimbra; Xitong Dang; Nicole Lopez; Jisook Lee; Michael Krzyzaniak; Robert Winfield; Bruce Potenza; Brian P Eliceiri
Journal:  J Leukoc Biol       Date:  2012-03-06       Impact factor: 4.962

2.  The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.

Authors:  Jenny L Wilkerson; Erin D Milligan
Journal:  ISRN Anesthesiol       Date:  2011

3.  Pleural macrophages are the dominant cell population in the thoracic cavity with an inflammatory cytokine profile similar to peritoneal macrophages.

Authors:  Akihiro Shimotakahara; Joachim F Kuebler; Gertrud Vieten; Martin L Metzelder; Claus Petersen; Benno M Ure
Journal:  Pediatr Surg Int       Date:  2007-05       Impact factor: 1.827

Review 4.  Immune-to-brain signaling: how important are the blood-brain barrier-independent pathways?

Authors:  Ning Quan
Journal:  Mol Neurobiol       Date:  2008-06-19       Impact factor: 5.590

5.  Use of laser capture microdissection for the assessment of equine lamellar basal epithelial cell signalling in the early stages of laminitis.

Authors:  B S Leise; M R Watts; S Roy; A S Yilmaz; H Alder; J K Belknap
Journal:  Equine Vet J       Date:  2014-08-19       Impact factor: 2.888

6.  A two-compartment mathematical model of endotoxin-induced inflammatory and physiologic alterations in swine.

Authors:  Gary Nieman; David Brown; Joydeep Sarkar; Brian Kubiak; Cordelia Ziraldo; Joyeeta Dutta-Moscato; Christopher Vieau; Derek Barclay; Louis Gatto; Kristopher Maier; Gregory Constantine; Timothy R Billiar; Ruben Zamora; Qi Mi; Steve Chang; Yoram Vodovotz
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

7.  A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shock.

Authors:  M Piccioni; C Monari; S Kenno; E Pericolini; E Gabrielli; D Pietrella; S Perito; F Bistoni; T R Kozel; A Vecchiarelli
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

8.  Systemic inflammatory response syndrome in nonhuman primates culminating in multiple organ failure, acute lung injury, and disseminated intravascular coagulation.

Authors:  Renee R Hukkanen; H Denny Liggitt; Robert D Murnane; Charles W Frevert
Journal:  Toxicol Pathol       Date:  2009-10       Impact factor: 1.902

9.  Urotensin receptors as a new target for CLP induced septic lung injury in mice.

Authors:  Elif Cadirci; Rustem Anil Ugan; Busra Dincer; Betul Gundogdu; Irfan Cinar; Erol Akpinar; Zekai Halici
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-24       Impact factor: 3.000

Review 10.  The stressed host response to infection: the disruptive signals and rhythms of systemic inflammation.

Authors:  Stephen F Lowry
Journal:  Surg Clin North Am       Date:  2009-04       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.